Assessing the post-treatment therapeutic effect of tongxie in irritable bowel syndrome: A randomized controlled trial

• প্রধান লেখক: Yaoliang Lai (লেখক), Xiao Liang (লেখক), Heng Fan (লেখক), Yujin Liu (লেখক), Liang Zheng (লেখক), Weimin Lu (লেখক), Yuling Sun (লেখক), Dawei Huang (লেখক), Xingxing Liu (লেখক), Lijian Zhang (লেখক), Dongmei Zuo (লেখক), Zhexing Shou (লেখক), Qing Tang (লেখক), Yuanyuan Wang (লেখক), Zhen Li (লেখক), Zhengyan Jiang (লেখক), Shuo Zang (লেখক), Huisuo Huang (লেখক), Zongxiang Tang (লেখক), Qian Li (লেখক), Jun Xiao (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Elsevier, 2022-09-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Diarrhea predominant irritable bowel syndrome (IBS) is a highly relapsing gastrointestinal disorder decreasing the quality of life. Existing studies indicated that the therapeutic effects maintained for a period of time after the treatments were discontinued (post-treatment therapeutic effects or PT...